Manish Agrawal

Founder & CEO

Pharmaceutical medicine manufacturers play a pivotal role in shaping modern healthcare by transforming scientific research into accessible and effective treatment solutions. In a market like India, where healthcare needs are expanding rapidly across acute, chronic, and preventive care, manufacturers are expected to do much more than produce medicines at scale. They must ensure quality, affordability, innovation, and trust at every stage of the value chain. It is within this evolving landscape that 9M Lifesciences has emerged as a promising name. As part of the larger 9M Group, the company is steadily building its presence in the Indian pharmaceutical space through science-backed offerings, patient-centric thinking, and a strong commitment to quality and ethical growth.

A Young Company with a Strong Legacy

What makes 9M Lifesciences particularly noteworthy is that while it is a young company in the branded prescription segment, it draws strength from the larger legacy of the 9M Group. The group has already spent more than a decade building its expertise across healthcare and pharmaceutical manufacturing through its different entities, including 9M India and 9M Care. This broader ecosystem gives 9M Lifesciences a distinct advantage: it is not starting from scratch, but rather building on an established foundation of manufacturing capability, healthcare understanding, and market experience.

The company entered the ethical pharmaceutical market with a clear purpose to bridge therapy gaps with relevant, science-based products rather than simply add more molecules to an already crowded market. This approach reflects a deeper understanding of the modern healthcare environment, where doctors and patients alike are looking for solutions that are clinically meaningful, reliable, and capable of improving outcomes. From the very beginning, 9M Lifesciences has positioned itself as an organization that values substance over noise, and scientific relevance over short-term commercial gain.

Science-Led Solutions for Real Patient Needs

At the heart of 9M Lifesciences is a simple but powerful philosophy: healthcare today requires meaningful medi­cal solutions supported by science, trust, and responsible engagement. The company’s focus is not limited to product availability; it is centered on product relevance. Its portfolio spans multiple specialties, including gastroenterology, ortho­pedics, ENT, respiratory care, nutraceuticals, and multispe­cialty segments, each aligned with real and evolving patient needs.

This science-driven philosophy also shapes how the com­pany approaches market expansion. Rather than growing indiscriminately, 9M Lifesciences is building its presence around areas where patient need, clinical relevance, and doc­tor acceptance intersect. Some of its products in the GI seg­ment, for instance, have already gained encouraging traction among healthcare professionals, signaling the company’s ability to identify and serve meaningful treatment spaces. The roadmap ahead includes expansion into chronic and specialty-driven segments such as metabolic care and gyne­cology, with the long-term goal of creating multiple focused divisions serving core therapeutic areas.

The company’s emphasis on science is equally reflected in the way it engages with healthcare professionals. "We strongly advocate transparent communication, scientific accuracy, and ethical marketing practices. In an industry where credibility is a decisive factor, our commitment helps the company build enduring trust with doctors, partners, and patients," says Sakshi Gupta, Vice President.

Built on Quality, Compliance, and Manufacturing Strength

One of the strongest pillars supporting 9M Lifesciences is its manufacturing backbone. The company benefits from the capabilities of the parent group’s WHO-GMP certified manufacturing facility in Chhattisgarh, which has served as a strong base for quality-driven production. This infrastructure not only enables 9M to maintain stringent quality standards but also supports its goal of making innovative products available at affordable prices.

Quality and compliance are not treated as formalities at 9M Lifesciences; they are embedded into the operating philosophy. The manufacturing ecosystem is designed to produce globally compliant, world-class pharmaceutical products across multiple dosage formats, including tablets, capsules, eye drops, and injectables. The group also works with advanced drug delivery system technologies aimed at improving patient compliance and clinical outcomes, which is increasingly critical in long-term treatment regimens.
 

This manufacturing strength also contributes to one of the company’s key differentiators: balancing quality with cost-effectiveness. In a healthcare environment where affordability can significantly influence treatment adherence, the ability to deliver dependable products at accessible prices becomes a major advantage. For 9M Lifesciences, this balance is not just a business objective; it is central to its patient-centric mission.

A Vision for Pan-India and Beyond

Despite being only around a year into its journey as 9M Lifesciences, the company has already made its presence felt across several regions of India. Starting from Western India, it has expanded into multiple parts of the country and is now working toward becoming a pan-India company within the current financial cycle. This pace of growth reflects both ambition and execution discipline, backed by a group structure that is already active in pharmaceutical manufacturing, healthcare devices, and international business.

The future vision of 9M Lifesciences is expansive yet focused. The company aims to evolve into a globally respected healthcare player known not just for medicines, but for innovation, ethical leadership, and meaningful partnerships. As the larger 9M Group deepens its presence in international markets, particularly in Africa, and broadens its offerings across healthcare devices and digital-first solutions, 9M Lifesciences is poised to be an important driver of this integrated healthcare ecosystem.

In the years ahead, the company sees itself as more than a pharmaceutical brand. "We aspire to become part of a unified healthcare platform where medicines, devices, diagnostics, and technology come together under one roof. That vision, grounded in science and executed with intent, positions 9M Lifesciences as a company to watch in India’s evolving healthcare landscape," concludes Nusrat Mujawar, GPM